Search results for "embolism"

showing 10 items of 457 documents

Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

2019

Abstract Background and aims Sex-specific differences exist for the initial presentation of acute venous thromboembolism (VTE): men are more likely to present with proximal deep vein thrombosis (DVT) in the lower limbs (versus pulmonary embolism [PE] or isolated distal DVT [IDDVT]) than women. We studied in detail the influence of sex, age, and VTE risk factors on the initial presentation of IDDVT versus proximal DVT. Methods A total of 24,911 patients with a first episode of objectively diagnosed acute symptomatic lower-limb DVT (without symptomatic PE) were enrolled in RIETE (years 2000–2017) and included in the present analysis. Results A total of 4266 (17.1%) patients had IDDVT. No tren…

medicine.medical_specialtyEpidemiologyDeep vein030204 cardiovascular system & hematologyDistal DVT03 medical and health sciences0302 clinical medicineDeep vein thrombosiDeep vein thrombosisInternal medicineEpidemiologymedicinecardiovascular diseasesFirst episodePregnancyProvoking risk factorsbusiness.industryCancerHematologymedicine.diseaseThrombosisPathophysiologyPulmonary embolismmedicine.anatomical_structureProvoking risk factor030220 oncology & carcinogenesisSexbusinessVenous thromboembolism
researchProduct

Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies

2019

The inverse association between physical activity and arterial thrombotic disease is well established. Evidence on the association between physical activity and venous thromboembolism (VTE) is divergent. We conducted a systematic review and meta-analysis of published observational prospective cohort studies evaluating the associations of physical activity with VTE risk. MEDLINE, Embase, Web of Science, and manual search of relevant bibliographies were systematically searched until 26 February 2019. Extracted relative risks (RRs) with 95% confidence intervals (CIs) for the maximum versus minimal amount of physical activity groups were pooled using random effects meta-analysis. Twelve article…

medicine.medical_specialtyEpidemiologyvenous thromboembolismphysical activity030204 cardiovascular system & hematologyliikunta03 medical and health sciences0302 clinical medicinesystematic reviewRisk FactorsInternal medicineEpidemiologymedicinecohort studyHumans030212 general & internal medicineRisk factorProspective cohort studykohorttitutkimusExercisebusiness.industryPhysical activitymeta-analyysiPublication biasriskitekijätVenous Thromboembolismmeta-analysisrisk factorMeta-analysisRelative risksydän- ja verisuonitauditSystematic reviewRisk factortromboosibusinessCohort studyBody mass indexfyysinen aktiivisuusCohort studyMeta-AnalysisEuropean Journal of Epidemiology
researchProduct

Fatal air embolism resulting from gastroscopy

1995

medicine.medical_specialtyFatal outcomeEmbolismbusiness.industrymedicineMEDLINEGeneral Medicinemedicine.diseaseIntensive care medicinebusinessAir embolismThe Lancet
researchProduct

Thrombolysis for massive pulmonary embolism in pregnancy: a case report

2011

Mortality from pulmonary embolism (PE) in pregnancy might be related to challenges in targeting the right population for prevention. Such targeting could help ensure that the correct diagnosis is suspected and adequately investigated, and allow the initiation of the timely and best possible treatment of this disease. In the literature to date only 18 case reports of thrombolysis in pregnant women with PE have been reported, and showed beneficial effects for both mother and fetus in terms of mortality and complications with acceptable bleeding risks. We present here the case of a pregnant patient with massive PE who underwent successful thrombolysis. A 26-year-old pregnant (at 24 weeks) woma…

medicine.medical_specialtyFetusPregnancyeducation.field_of_studymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPopulationCase ReportThrombolysisChest painmedicine.diseasePulmonary embolismmedicine.anatomical_structureInternal medicineEmergency MedicinemedicineCardiologyInterventricular septummedicine.symptombusinesseducationPelvic examinationInternational Journal of Emergency Medicine
researchProduct

Letter regarding article titled ‘Microembolism during foam sclerotherapy of varicose veins’ in the New England Journal of Medicine

2008

medicine.medical_specialtyForamen ovale patentHeart Diseasesbusiness.industrymedicine.medical_treatmentSclerosing SolutionsForamen Ovale PatentGeneral MedicineSclerosing SolutionsSurgeryVaricose VeinsNew englandPractice Guidelines as TopicSclerotherapyVaricose veinsmedicineSclerotherapyEmbolism AirHumansmedicine.symptomCardiology and Cardiovascular MedicinebusinessUltrasonographyPhlebology: The Journal of Venous Disease
researchProduct

2021

AIMS/INTRODUCTION In patients with pulmonary embolism (PE), the impact of diabetes mellitus on patient profile and outcome is not well investigated. MATERIAL AND METHODS The German nationwide inpatient sample of the years 2005-2018 was analyzed. Hospitalized PE patients were stratified for diabetes, and the impact of diabetes on in-hospital events was investigated. RESULTS Overall, 1,174,196 PE patients (53.8% aged ≥70 years, 53.5% women) and, among these, 219,550 (18.7%) diabetes patients were included. In-hospital mortality rate amounted to 15.8%, and was higher in diabetes patients than in non-diabetes patients (19.8% vs 14.8%, P < 0.001). PE patients with diabetes had a higher prevalenc…

medicine.medical_specialtyGastrointestinal bleedingbusiness.industryEndocrinology Diabetes and MetabolismMortality rateGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalPulmonary embolismInternal medicineDiabetes mellitusInternal MedicinemedicineRisk factorbusinessAdverse effectJournal of Diabetes Investigation
researchProduct

Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.

2021

With increasing life-expectancy and changing demographics, non-valvular atrial fibrillation (AF) is currently the most common indication for long-term oral anticoagulation (OAC) in low and middle income countries (LMICs). Due to a decreasing trend in the prevalence of rheumatic heart disease (RHD), valve disease as a primary cause of AF now constitutes a small fraction of all people with AF. Moreover, emerging data also indicate that, patients with significant valve disease and AF may have a risk of stroke similar to, if not lower than, those with non-valvular AF. Previous trials of anticoagulation for AF excluded people from LMICs partly because valvular AF constituted a large proportion o…

medicine.medical_specialtyHeart diseaseRD1-811medicine.drug_classMEDLINEAdministration Oral030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineThromboembolismAtrial FibrillationOpinion PapermedicineDiseases of the circulatory (Cardiovascular) systemHumans030212 general & internal medicineMedical prescriptionIntensive care medicineStrokeDeveloping Countriesbusiness.industryvalvular heart diseaseAnticoagulantsAtrial fibrillationVitamin K antagonistmedicine.diseaseClinical trialStrokeRC666-701SurgeryCardiology and Cardiovascular MedicinebusinessIndian heart journal
researchProduct

Nickel release after implantation of the Amplatzer occluder.

2003

Background Transcatheter closure of atrial septal defects is a new and less traumatic technique than open heart surgery. In recent years, patients with a patent foramen ovale sustaining potential paradoxical embolism have also become candidates for interventional closure devices. One of the more popular occluding devices is the Amplatzer septal occluder, which, like many other occluders, is made of nitinol. Nitinol-based alloys are widely used in medical products, for example, in orthopedics and orthodontics. However, the clinical use of nitinol, which contains 55% nickel, is still controversial because of concerns about its biocompatibility. Therefore, we examined the systemic nickel relea…

medicine.medical_specialtyHeart septal defectCardiac CatheterizationHeart diseasebusiness.industryAmplatzer Septal Occluderchemistry.chemical_elementProstheses and Implantsmedicine.diseaseProsthesis DesignAtrial septal defectsHeart Septal Defects AtrialSurgeryNickelParadoxical embolismchemistryNickelPatent foramen ovalemedicineAlloysHumansCardiology and Cardiovascular MedicinebusinessComplicationAmerican heart journal
researchProduct

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis

2018

Aims Controversial reports exist in the literature regarding the prognostic role and therapeutic implications of syncope in patients with acute pulmonary embolism (PE). We conducted a systematic review and meta-analysis to investigate the association between syncope and short-term adverse outcomes, taking into account the presence or absence of haemodynamic compromise at acute PE presentation. Methods and results The literature search identified 1664 studies, 29 of which were included for a total of 21 956 patients with PE (n = 3706 with syncope). Syncope was associated with higher prevalence of haemodynamic instability [odds ratio (OR) 3.50; 95% confidence interval (CI) 2.67-4.58], as well…

medicine.medical_specialtyHemodynamicsBlood Pressure030204 cardiovascular system & hematologyGlobal HealthSyncopeRisk-stratification03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineMortalityRight ventricular dysfunctionbiologybusiness.industryIncidence (epidemiology)IncidencePulmonary embolismSyncope (genus)Absolute risk reductionOdds ratiomedicine.diseasebiology.organism_classificationPrognosisConfidence interval3. Good healthPulmonary embolismSurvival RateEchocardiographyMeta-analysisAcute DiseasebusinessCardiology and Cardiovascular Medicine
researchProduct

Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism

2021

Venous thromboembolism (VTE) constitute a major global burden of disease. Current international guidelines recommend treatment with anticoagulant therapy after VTE for a duration of at least 3 months. Since anticoagulation also imposes an increased risk for bleeding events, the individual risk has to be evaluated to determine adequate treatment plans.The nationwide German inpatient sample of the years 2005-2017 was used for this analysis. Hospitalized VTE patients were stratified according to Kuijer risk class and the performance of the Kuijer score was evaluated to predict adverse in-hospital events.Overall, 1,204,895 VTE patients were treated between 2005 and 2017 in Germany and were incl…

medicine.medical_specialtyHemorrhage030204 cardiovascular system & hematologyThrombophlebitis03 medical and health sciences0302 clinical medicineRisk FactorsInterquartile rangeGermanyInternal medicinemedicineHumansIn patientHospital Mortality030212 general & internal medicinebusiness.industryAnticoagulantsVenous ThromboembolismOdds ratiomedicine.diseaseHospitalsConfidence intervalPulmonary embolismVenous thrombosisCardiology and Cardiovascular MedicinebusinessVenous thromboembolismInternational Journal of Cardiology
researchProduct